LIFAMBY
Live / Allowed — Fourth extension granted (statement of use) (as of 20 Apr 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Apr 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 97909415
- Mark type
- Word mark
- Filed
- 26 Apr 2023
- Published for opposition
- 05 Mar 2024
- Attorney of record
- Terrence J. McAllister
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral diseases and disorders, and for the treatment of pain
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Prosecution history
- 28 Oct 2026 — SOU TEAS EXTENSION RECEIVED
- 20 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Apr 2026 — SOU EXTENSION 4 GRANTED
- 20 Apr 2026 — SOU EXTENSION 4 FILED
- 20 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Oct 2025 — SOU EXTENSION 3 GRANTED
- 10 Oct 2025 — SOU EXTENSION 3 FILED
- 10 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 30 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Apr 2025 — SOU EXTENSION 2 GRANTED
- 29 Apr 2025 — SOU EXTENSION 2 FILED